A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides
Andrea Guerrini(Institute of Organic Synthesis and Photoreactivity), Greta Varchi(Institute of Organic Synthesis and Photoreactivity), Alice Zamagni(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Carlo Leonetti(National Cancer Institute), Giulia Paganelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Silvia Carloni(University of Urbino), Giovanni Luca Beretta(Fondazione IRCCS Istituto Nazionale dei Tumori), Claudia Ferroni(Institute of Organic Synthesis and Photoreactivity), Anna Tesei(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Marzia Di Donato(University of Campania "Luigi Vanvitelli"), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Michelandrea De Cesare(Fondazione IRCCS Istituto Nazionale dei Tumori), Alberto Del Río(Institute of Organic Synthesis and Photoreactivity), Gabriella Castoria(University of Campania "Luigi Vanvitelli"), Manuela Porru(National Cancer Institute)
Cited by 73
Related Papers
ROS in cancer therapy: the bright side of the moon
|Experimental & Molecular Medicine|2020|2.2k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
|Scientific Reports|2016|1.1k